Document is current
Any future updates will be listed below
-
Authors
Malmgren, Linnea
McGuigan, Fiona E.
Christensson, Anders
Akesson, Kristina E.
-
Funding
Funding for this research was provided by:
Skåne University Hospital Research Fund
Syskonen Lundgrens stiftelse
ALF
Vetenskapsrådet (K2015-52X-14691-13-4)
Vetenskapsrådet (K2015-52X-14691-13-4)
Greta och Johan Kocks stiftelser
Direktör Albert Påhlssons Stiftelse
Herman Järnhardt Foundation
Stiftelsen Konung Gustaf V:s 80-årsfond
Swedish Rheumatism foundation
Kungliga Fysiografiska Sällskapet i Lund
Njurstiftelsen
research and development council of Region Skåne
Lund University
- License Information
-
More Information
Article History
Received: 1 July 2021
Accepted: 15 November 2021
First Online: 24 January 2022
Competing interests
: The authors declare no competing interests. L. Malmgren has received lecture fees from Amgen. K. Åkesson has received lecture fees from Amgen, Eli Lilly, Renapharma, UCB Pharma. All other authors have nothing to disclose.
